| Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer SM Swain, J Baselga, SB Kim, J Ro, V Semiglazov, M Campone, ... New England journal of medicine 372 (8), 724-734, 2015 | 2418 | 2015 |
| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 1982 | 2016 |
| Palbociclib in hormone-receptor–positive advanced breast cancer NC Turner, J Ro, F André, S Loi, S Verma, H Iwata, N Harbeck, S Loibl, ... New England Journal of Medicine 373 (3), 209-219, 2015 | 1766 | 2015 |
| Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015 | 1551 | 2015 |
| Micrometastases or isolated tumor cells and the outcome of breast cancer M De Boer, CHM Van Deurzen, JAAM Van Dijck, GF Borm, PJ Van Diest, ... New England Journal of Medicine 361 (7), 653-663, 2009 | 613 | 2009 |
| Breast-cancer adjuvant therapy with zoledronic acid RE Coleman, H Marshall, D Cameron, D Dodwell, R Burkinshaw, ... New England Journal of Medicine 365 (15), 1396-1405, 2011 | 555 | 2011 |
| Effect of occult metastases on survival in node-negative breast cancer DL Weaver, T Ashikaga, DN Krag, JM Skelly, SJ Anderson, SP Harlow, ... New England Journal of Medicine 364 (5), 412-421, 2011 | 512 | 2011 |
| An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement E Barranger, C Coutant, A Flahault, Y Delpech, E Darai, S Uzan Breast cancer research and treatment 91, 113-119, 2005 | 328 | 2005 |
| Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study C Coutant, C Olivier, E Lambaudie, E Fondrinier, F Marchal, F Guillemin, ... Journal of Clinical Oncology 27 (17), 2800-2808, 2009 | 297 | 2009 |
| Randomized trial of laparoscopically assisted versus open colorectal resection for endometriosis: morbidity, symptoms, quality of life, and fertility E Daraï, G Dubernard, C Coutant, C Frey, R Rouzier, M Ballester Annals of Surgery 251 (6), 1018-1023, 2010 | 288 | 2010 |
| In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival S Ladoire, G Mignot, S Dabakuyo, L Arnould, L Apetoh, C Rébé, ... The Journal of pathology 224 (3), 389-400, 2011 | 277 | 2011 |
| Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer T Iwamoto, G Bianchini, D Booser, Y Qi, C Coutant, C Ya-Hui Shiang, ... Journal of the National Cancer Institute 103 (3), 264-272, 2011 | 259 | 2011 |
| Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer A Tabchy, V Valero, T Vidaurre, A Lluch, H Gomez, M Martin, Y Qi, ... Clinical Cancer Research 16 (21), 5351-5361, 2010 | 234 | 2010 |
| Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor–positive and–negative cancers G Bianchini, Y Qi, RH Alvarez, T Iwamoto, C Coutant, NK Ibrahim, ... Journal of Clinical Oncology 28 (28), 4316-4323, 2010 | 227 | 2010 |
| Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis AR Ferreira, A Di Meglio, B Pistilli, AS Gbenou, M El-Mouhebb, S Dauchy, ... Annals of Oncology 30 (11), 1784-1795, 2019 | 186 | 2019 |
| Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer O Graesslin, BS Abdulkarim, C Coutant, F Huguet, Z Gabos, L Hsu, ... Journal of clinical oncology 28 (12), 2032-2037, 2010 | 179 | 2010 |
| Anaphylactic response to blue dye during sentinel lymph node biopsy C Bézu, C Coutant, A Salengro, E Daraï, R Rouzier, S Uzan Surgical oncology 20 (1), e55-e59, 2011 | 172 | 2011 |
| Just how accurate are the major risk stratification systems for early-stage endometrial cancer? S Bendifallah, G Canlorbe, P Collinet, E Arsène, F Huguet, C Coutant, ... British journal of cancer 112 (5), 793-801, 2015 | 148 | 2015 |
| Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic-FRANCOGYN group for the CNGOF C Akladios, H Azais, M Ballester, S Bendifallah, PA Bolze, N Bourdel, ... Journal of gynecology obstetrics and human reproduction 49 (6), 101729, 2020 | 118 | 2020 |
| Breast‐conserving surgery after neoadjuvant anthracycline‐based chemotherapy for large breast tumors R Rouzier, MC Mathieu, L Sideris, E Youmsi, R Rajan, JR Garbay, ... Cancer 101 (5), 918-925, 2004 | 117 | 2004 |
